522 related articles for article (PubMed ID: 3922606)
1. Cyclosporine in heart and heart-lung transplantation.
Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
[TBL] [Abstract][Full Text] [Related]
2. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardiac rejection in heart and heart-lung transplantation.
Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of combined heart-lung transplantation: the Stanford experience.
Sarris GE; Smith JA; Shumway NE; Stinson EB; Oyer PE; Robbins RC; Billingham ME; Theodore J; Moore KA; Reitz BA
J Heart Lung Transplant; 1994; 13(6):940-9. PubMed ID: 7865527
[TBL] [Abstract][Full Text] [Related]
7. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
Lough ME; Miller JL; Gamberg P
J Heart Transplant; 1986; 5(4):322-6. PubMed ID: 3305825
[TBL] [Abstract][Full Text] [Related]
8. Eight-year results of cyclosporine-treated patients with cardiac transplants.
Grattan MT; Moreno-Cabral CE; Starnes VA; Oyer PE; Stinson EB; Shumway NE
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):500-9. PubMed ID: 2308368
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in cardiac transplantation.
Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
[TBL] [Abstract][Full Text] [Related]
12. Heart-lung xenotransplantation in primates.
Sadeghi AM; Laks H; Drinkwater DC; Pearl JM; Chang P; Haas G; Burnison CM; Horton D
J Heart Lung Transplant; 1991; 10(3):442-7; discussion 447-8. PubMed ID: 1854771
[TBL] [Abstract][Full Text] [Related]
13. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients.
Glanville AR; Imoto E; Baldwin JC; Billingham ME; Theodore J; Robin ED
J Heart Transplant; 1987; 6(6):357-61. PubMed ID: 3121820
[TBL] [Abstract][Full Text] [Related]
14. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
15. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
Olivari MT; Antolick A; Ring WS
J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
17. Heart and lung transplantation for pulmonary hypertension.
Jamieson SW; Stinson EB; Oyer PE; Theodore J; Hunt S; Dawkins K; Billingham M; Shumway NE
Am J Surg; 1984 Jun; 147(6):740-2. PubMed ID: 6428246
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.
Brumbaugh J; Baldwin JC; Stinson EB; Oyer PE; Jamieson SW; Bieber CP; Henle W; Shumway NE
J Heart Transplant; 1985 May; 4(3):307-11. PubMed ID: 3039097
[TBL] [Abstract][Full Text] [Related]
19. Treatment of moderate heart allograft rejection with cyclosporine.
Radovancevic B; Frazier OH
J Heart Transplant; 1986; 5(4):307-11. PubMed ID: 3114444
[TBL] [Abstract][Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
